ARTA
APYX icon

A.R.T. Advisors’s Apyx Medical APYX Stock Holding History

A.R.T. Advisors’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,689
Closed -$69K – 1298
2018
Q4 		$69K Buy
+10,689
New +$64.7K ﹤0.01% 1192
2018
Q2 		– Sell
-13,736
Closed -$40K – 1403
2018
Q1 		$40K Buy
+13,736
New +$35.3K ﹤0.01% 1415

Other funds holding APYX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

A.R.T. Advisors's APYX Position: Q1 2019 in Review

A.R.T. Advisors sold out of Apyx Medical (APYX) in Q1 2019, closing a stake of 10,689 shares — an estimated $69K sold.

A.R.T. Advisors first reported a position in APYX in Q1 2018 and held it in 2 quarters. The position peaked at $69K in Q4 2018. 78 funds tracked by Wall St. Rank hold APYX as of Q1 2019.

  • A.R.T. Advisors reported no remaining Apyx Medical position as of Q1 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 10,689 Apyx Medical shares in Q1 2019, an estimated $69K.
  • A.R.T. Advisors first reported a position in Apyx Medical in Q1 2018 and held it in 2 quarters.
  • A.R.T. Advisors's Apyx Medical position peaked at $69K in Q4 2018.
  • 78 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2019.

Based on A.R.T. Advisors's 13F filing for Q1 2019, filed 15 May 2019.